|
Alectinib Hydrochloride
|
艾乐替尼盐酸盐
|
1256589-74-8
|
|
CH7057288
|
CH7057288
|
2095616-82-1
|
|
venetoclax Dechlorination impurities
|
维奈克拉脱氯杂质
|
2573767-91-4
|
|
Benzamide, 4-fluoro-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
|
维奈克拉杂质
|
2573767-90-3
|
|
RMC7977
|
泛KRAS抑制剂
|
2765082-12-8
|
|
Fosaprepitant
|
福沙吡坦
|
172673-20-0
|
|
RMC9805
|
|
|
|
PEG 4000 4-(3-(1-acryloyloxyethyl)-4-nitrophenoxy) butanoate
|
4-(3-(1-丙烯酰氧乙基) -4-硝基苯氧基)丁酸 聚乙二醇4000酯
|
|
|
Salmeterol xinafoate
|
昔美酸沙美特罗
|
94749-08-3
|
|
DEUTERIUM OXIDE
|
重水
|
7789-20-0
|
|
1H-Benzimidazol-4-amine, 5-bromo-1,2-dimethyl-6-(trifluoromethyl)-
|
5-溴-1,2-二甲基-6-(三氟甲基)-1H-苯并[d]咪唑-4-胺
|
2858644-42-3
|
|
Piperazine, 1-[(4,4-dimethyl-2-phenyl-1-cyclohexen-1-yl)methyl]-, hydrochloride (1:2)
|
维奈克拉脱氯杂质
|
2227206-06-4
|
|
RM018
|
RM018
|
2641993-55-5
|
|
Fosaprepitant dimeglumine
|
福沙吡坦二甲葡胺
|
265121-04-8
|
|
Alectinib base
|
艾乐替尼游离碱
|
1256580-46-7
|
|
Methyl (αS,2S)-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate
|
(aS,2S)-Α-[(苯基甲氧基)羰基]氨基]-2-吗啉丙酸甲酯
|
2641824-62-4
|
|
Mirogabalin besylate
|
苯磺酸米洛巴林
|
1138245-21-2
|
|
1-Piperazinecarboxylic acid, 4-[6-[(1S)-1-methoxyethyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-, phenylmethyl ester
|
(S)-5-(4-CBZ-1-哌嗪基)-2-(1-甲氧基乙基)吡啶-3-硼酸频哪醇酯
|
2641451-79-6
|
|
(S)-N-(5-((S)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
拉罗替尼异构体杂质
|
2409589-59-7
|
|
6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid
|
艾乐替尼中间体
|
1256584-78-7
|
|
Alectinib intermediate
|
艾乐替尼中间体
|
1256698-41-5
|
|
Methyl (S)-hexahydropyridazine-3-carboxylate hydrochloride
|
(S)-六氢哒嗪-3-羧酸甲酯盐酸盐
|
380223-17-6
|
|
pan Kras-int
|
|
2764998-33-4
|
|
5-bromo-1,2-dimethyl-6-(trifluoromethyl)-1H-benzo[d]imidazole
|
|
2641795-11-9
|